P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000845612.25766.0c |
| _version_ | 1797287882836148224 |
|---|---|
| author | J. Woyach I. W. Flinn F. T. Awan H. Eradat D. Brander M. Tees S. A. Parikh T. Phillips W. Wang N. M. Reddy M. Z. Farooqui J. C. Byrd D. M. Stephens |
| author_facet | J. Woyach I. W. Flinn F. T. Awan H. Eradat D. Brander M. Tees S. A. Parikh T. Phillips W. Wang N. M. Reddy M. Z. Farooqui J. C. Byrd D. M. Stephens |
| author_sort | J. Woyach |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:15Z |
| format | Article |
| id | doaj.art-24921f3fec2c4a1eb7cd2ffd7d2d0db1 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:15Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-24921f3fec2c4a1eb7cd2ffd7d2d0db12024-03-02T03:51:52ZengWileyHemaSphere2572-92412022-06-01657857910.1097/01.HS9.0000845612.25766.0c202206003-00578P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDYJ. Woyach0I. W. Flinn1F. T. Awan2H. Eradat3D. Brander4M. Tees5S. A. Parikh6T. Phillips7W. Wang8N. M. Reddy9M. Z. Farooqui10J. C. Byrd11D. M. Stephens121 Division of Hematology, The Ohio State University, Columbus, Columbus2 Sarah Cannon Center Research Institute, Nashville, Nashville3 Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas4 Department of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles5 Duke Cancer Institute, Duke University Medical Center, Durham6 Colorado Blood Cancer Institute, Denver7 Division of Hematology, Mayo Clinic, Rochester8 Division of Hematology and Oncology, University of Michigan Rogel Cancer Center, Ann Arbor9 Veristat, LLC, Southborough10 Merck & Co., Inc., Kenilworth10 Merck & Co., Inc., Kenilworth11 Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati12 Division of Hematology and Hematologic Malignancies, University of Utah Huntsman Cancer Institute, Salt Lake City, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000845612.25766.0c |
| spellingShingle | J. Woyach I. W. Flinn F. T. Awan H. Eradat D. Brander M. Tees S. A. Parikh T. Phillips W. Wang N. M. Reddy M. Z. Farooqui J. C. Byrd D. M. Stephens P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY HemaSphere |
| title | P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY |
| title_full | P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY |
| title_fullStr | P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY |
| title_full_unstemmed | P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY |
| title_short | P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY |
| title_sort | p682 nemtabrutinib mk 1026 a non covalent inhibitor of wild type and c481s mutated bruton tyrosine kinase for b cell malignancies efficacy and safety of the phase 2 dose expansion bellwave 001 study |
| url | http://journals.lww.com/10.1097/01.HS9.0000845612.25766.0c |
| work_keys_str_mv | AT jwoyach p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT iwflinn p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT ftawan p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT heradat p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT dbrander p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT mtees p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT saparikh p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT tphillips p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT wwang p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT nmreddy p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT mzfarooqui p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT jcbyrd p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study AT dmstephens p682nemtabrutinibmk1026anoncovalentinhibitorofwildtypeandc481smutatedbrutontyrosinekinaseforbcellmalignanciesefficacyandsafetyofthephase2doseexpansionbellwave001study |